Currently, major efforts have been made to develop some anticancer therapies based on the small molecules that specifically target DNA demethylating protein or EGFR, whereas, not much information is known about the combined effects of EGFR inhibitors and demethylating agents in colon cancer. Here, EGFR is linked to malignant colon neoplasm.